Inside China’s Pharma Sales Force – insights from the frontline
[Lowest Price Guaranteed: $695]
Published by FirstWord Pharma: 01 Jul 2013 | 49 | In Stock
In 2011, China’s pharmaceutical sales force exceeded that of the U.S. for the first time. However, very little data is available on China’s sales operations and tactics. FirstWord’s new report sheds light on how Pharma is using its still-expanding Chinese sales force, with exclusive insights from sales managers at multinational and domestic companies
China’s economy is one of the fastest growing in the world, and its pharmaceutical industry is also experiencing extremely rapid growth. Just as in the U.S., Japan, and Europe, China’s pharma industry is also being transformed – with moves towards universal healthcare coverage, more ethical practices, and greater use of digital channels. However, China’s unique geography, government, and culture mean that local knowledge is essential to bring an understanding of what is happening on the ground.
In creating this much-needed report, FirstWord interviewed seven regional and district sales managers at western pharmaceutical companies operating in China. FirstWord also conducted interviews with regional and national sales managers at two Chinese companies to ascertain the differences in the way local and multinational companies operate their sales teams.
Along with exclusive research, this report is packed with useful information about China’s pharmaceutical industry, including an overview of the key Pharma companies investing in China, a city tiers reference, and a China-specific definition of a Key Opinion Leader.
Whether or not your company has a presence in China, understanding the Chinese sales force gives you a significant competitive edge. Download this illuminating new report today!
The benefits of this report
FirstWord’s new report fills that significant knowledge gap with exclusive statistics, trends, and expert commentary that comes straight from the source. Now you can compare your sales activities with those of other multinational and local companies in China, understand the current commercial environment in China, and stay ahead with insights into how it is expected to change. With this concise report, you will:
Selected quotes from the report
“In China, there is a social aspect to the relationship between the reps and the physicians, where very often personal free time is used to speak about the pharmaceutical products outside of the hospital setting.” Delphine Perridy, country manager China – regional director SEA, Cegedim Strategic Data
“In order to achieve a full cover of the ‘viable market’ you need between 80 and 400 distributors/wholesalers if you are to avoid having products going through one or two layers of distribution for more hospitals. The smaller the number of primary distributors that the company works with, the larger the number of total suppliers of their products as they will have a lack of control of the ‘route to market’.” Anonymous consultant
“We have a sales representative to see physicians at every level of the hospital. Above them we have key account managers and a regional manager. We also have a government affairs department which deals with government officials.” District Sales Manager from western pharma company
Table of Contents
for Inside China’s Pharma Sales Force – insights from the frontline
3.Methodology and acknowledgements
4.FirstWord would like to thank them for their input into this report without which it would not have been possible.
5.The pharmaceutical industry in China
6.Promotional activities in China
7.The pharmaceutical sales force in China
7.1.Sales force structure
7.2.Engaging with customers
7.2.1.Key opinion leader management in China
7.3.Profile of a sales rep in China
Number of Pages
|Title||Date Published||Price from||More Details|
|Biophotonics Market by Application(See-through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), Technology(In-vivo, In-vitro), End-use(Diagnostics, Therapeutic, Tests), & Geography - Global Forecast to 2020|
Emergence of nanotechnology and significant technological advancements in the field of biophotonics ...
|10 Nov 2015 by MarketsandMarkets||USD $5,650||More Info|
|Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma|
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
|01 Jun 2012 by FirstWord Pharma||USD $995||More Info|
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.